Research has shown wide variation in per capita spending among different states and among different counties within the same state. Some of this variation can be explained by the health status of the ...

Hospitals and health systems across the country are experiencing significant pressure to reduce costs and improve quality. The shift from volume to value continues to accelerate, being driven by ...

This study demonstrates that variation reduction is an important, but not requisite, component of organizational success under orthopedic bundled payment. Objectives: To describe the extent of and ...

Other factors, including the increasing prevalence of bundled payments, the Medicare Access and CHIP Reauthorization Act of 2015, the 30-day Hospital Readmissions Reduction Program and other ...

Addressing unwarranted clinical variation in oncology is a high priority for health systems that aspire to ensure consistent levels of high-quality and cost-effective care. Efforts to improve clinical ...

Lifepoint Health’s CMO shares key insights into reducing unwarranted clinical variation through a clinician-centered, analytics-driven approach. In today’s rapidly evolving healthcare landscape, ...

Topoisomerase II-alpha is a target of common chemotherapeutic agents such as doxorubicin and etoposide, which induce DNA damage by altering the activity of this enzyme. We took rectal biopsies at ...